Počet záznamů: 1  

Anticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats

  1. 1.
    SYSNO ASEP0542146
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevAnticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats
    Tvůrce(i) Mareš, Pavel (FGU-C) RID, ORCID
    Tsenov, Grygoriy (FGU-C) RID, ORCID
    Kubová, Hana (FGU-C) RID, ORCID
    Číslo článku415
    Zdroj.dok.Pharmaceutics. - : MDPI
    Roč. 13, č. 3 (2021)
    Poč.str.15 s.
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovaNMDA receptors ; GluN2A subunit ; anticonvulsant action ; pentylenetetrazol-induced seizures ; cortical epileptic afterdischarges ; immature rats
    Vědní obor RIVFR - Farmakologie a lékárnická chemie
    Obor OECDPharmacology and pharmacy
    CEPGA19-11931S GA ČR - Grantová agentura ČR
    GA18-09296S GA ČR - Grantová agentura ČR
    EF16_025/0007444 GA MZd - Ministerstvo zdravotnictví
    Způsob publikováníOpen access
    Institucionální podporaFGU-C - RVO:67985823
    UT WOS000634070000001
    EID SCOPUS85103080287
    DOI10.3390/pharmaceutics13030415
    AnotaceThe GluN2A subunit of N-methyl-D-aspartate (NMDA) receptors becomes dominant during postnatal development, overgrowing the originally dominant GluN2B subunit. The aim of our study was to show changes of anticonvulsant action of the GluN2A subunit-preferring antagonist during postnatal development of rats. Possible anticonvulsant action of GluN2A-preferring antagonist of NMDA receptors P = [[[(1S)-1-(4-bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]phosphonic acid tetrasodium salt (PEAQX) (5, 10, 20 mg/kg s.c.) was tested in 12-, 18-, and 25-day-old rats in three models of convulsive seizures. Pentylenetetrazol-induced generalized seizures with a loss of righting reflexes generated in the brainstem were suppressed in all three age groups in a dose-dependent manner. Minimal clonic seizures with preserved righting ability exhibited only moderately prolonged latency after the highest dose of PEAQX. Anticonvulsant action of all three doses of PEAQX against cortical epileptic afterdischarges (generated in the forebrain) was found in the 25-day-old animals. The highest dose (20 mg/kg) was efficient also in the two younger groups, which might be due to lower specificity of PEAQX and its partial affinity to the GluN2B subunit. Our results are in agreement with the postero-anterior maturation gradient of subunit composition of NMDA receptors (i.e., an increase of GluN2A representation). In spite of the lower selectivity of PEAQX, our data demonstrate, for the first time, developmental differences in comparison with an antagonist of NMDA receptors with a dominant GluN2B subunit.
    PracovištěFyziologický ústav
    KontaktLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Rok sběru2022
    Elektronická adresahttps://www.mdpi.com/1999-4923/13/3/415
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.